Intent to Sole Source: Pharmacy Services
ID: SS-AFRH-25-045Type: Special Notice
Overview

Buyer

TREASURY, DEPARTMENT OF THEBUREAU OF THE FISCAL SERVICEARC DIV PROC SVCS - AFRHPARKERSBURG, WV, 26101, USA

NAICS

Pharmacies and Drug Retailers (456110)

PSC

MEDICAL- PHARMACOLOGY (Q517)
Timeline
    Description

    The Department of the Treasury, specifically the Bureau of the Fiscal Service, is seeking to award a sole source contract for pharmacy services at the Armed Forces Retirement Home in Washington, D.C. The selected contractor, Pharmerica Corp., will be responsible for providing comprehensive pharmacy services, including medication dispensing and ancillary services, while ensuring compliance with all relevant state and federal regulations. This contract is crucial for maintaining the health and safety of approximately 555 veterans residing at the facility, with a contract period from April 1, 2025, to March 31, 2026. Interested vendors must submit their capability statements by 10:00 a.m. ET on March 13, 2025, to the primary contact, Kaity Eaton, at purchasing@fiscal.treasury.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Performance Work Statement (PWS) outlines the requirements for pharmacy services at the Armed Forces Retirement Home in Washington, DC (AFRH-W). Established in 1991, the AFRH provides a continuum of care for approximately 555 veterans. The contractor selected for pharmacy services must ensure compliance with state and federal laws while providing necessary medication dispensing and ancillary services for various resident populations, including those in long-term care and assisted living. The contract period is from April 1, 2025, to March 31, 2026, with expectations for continuous service availability, billing procedures to insurance providers, and emergency medication delivery. Key responsibilities include accurate medication dispensing, drug regimen reviews, and participation in quality assurance activities. Personnel qualifications are stringent, requiring licensed pharmacists and registered nurses. The contractor must implement a Quality Control Program to maintain standards, with performance evaluated through monthly reports and audits. Furthermore, insurance billing specifics and the government's non-responsibility for payments highlight financial protocols. The document establishes a framework for operational efficiency while ensuring the health and safety of the resident population. It reflects the government’s commitment to quality care for veterans through structured pharmacy services.
    The Armed Forces Retirement Home of Washington, D.C. (AFRH-W) intends to issue a sole source contract to Pharmerica Corp. for emergency pharmacy services, with a base period starting April 1, 2025. The contractor will be required to comply with all relevant state and federal standards, as well as AFRH policies. Written responses demonstrating vendor capability must be submitted by 10:00 a.m. ET on March 13, 2025. If no satisfactory responses are received, the contract will proceed solely to Pharmerica Corp. Interested vendors must provide their company details, including business size and capabilities, without including pricing at this stage. Submissions should be sent via email, adhering to specified file formats. The notice does not limit the Government's acquisition strategy; all participating vendors may need to respond to any future solicitation separately if deemed necessary. This procurement process emphasizes the necessity for qualified pharmacy services aligned with governmental standards.
    Lifecycle
    Title
    Type
    Special Notice
    Similar Opportunities
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotations for a Blanket Purchase Agreement (BPA) related to the Pharmacy Uniform Formulary and the Uniform Formulary Additional Discount Program. This procurement aims to secure pharmaceutical agents for inclusion in the DoD's integrated pharmacy benefits program, focusing on enhancing medication management for service members while ensuring cost-effectiveness and compliance with established pricing protocols. The initiative is particularly significant for managing high-value medications, such as those used in breast cancer treatment, and emphasizes the importance of accurate data representation and adherence to procedural changes within the Military Health System. Interested vendors must submit their quotes by March 20, 2025, and can direct inquiries to Tracy Banks at tracy.e.banks2.civ@health.mil or Julianne Canaley at julianne.m.canaley.ctr@health.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is issuing a Request for Quotation (RFQ) for pharmaceutical agents to be included in the Uniform Formulary under the TRICARE pharmacy benefit. This procurement aims to evaluate the clinical and cost-effectiveness of medications, allowing manufacturers to submit quotes for both the Uniform Formulary Blanket Purchase Agreement (UF BPA) and the Uniform Formulary Additional Discount Program (UF ADP). The selected pharmaceutical agents will be utilized in Military Treatment Facilities (MTFs) and the TRICARE retail network, emphasizing the importance of providing effective healthcare solutions while managing costs. Interested manufacturers must submit their quotes by March 20, 2025, and can direct inquiries to Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil or Tracy Banks at tracy.e.banks2.civ@health.mil.
    R602--Pharmacy Courier Services for the Troy Bowling Campus Veterans Affairs Medical Center located in Lexington, KY
    Buyer not available
    The Department of Veterans Affairs is seeking potential vendors to provide Pharmacy Courier Services for the Troy Bowling Campus Veterans Affairs Medical Center located in Lexington, KY. The procurement aims to establish a firm-fixed-price Blanket Purchase Agreement (BPA) for the secure transportation of pharmacy medications between specified VA campus locations, ensuring compliance with local and federal regulations while maintaining medication integrity during transit. This service is crucial for the timely and safe delivery of medications to veterans, adhering to HIPAA confidentiality standards and professional conduct. Interested parties must submit capability statements detailing their qualifications by March 11, 2025, with the BPA's performance period projected from April 15, 2025, to April 14, 2030. For further inquiries, contact Contract Specialist Dawn Collins at Dawn.Collins@va.gov or call 423-979-3640.
    6505--760-25-1-050-0237 -Leavenworth CMOP OM PHARMACEUTICALS -(VA-25-00028391)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a request for proposal (RFP) for the procurement of fourteen specified pharmaceuticals to be delivered to the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) facility in Kansas. This opportunity is exclusively set aside for small businesses under the product service code 6505, which pertains to drugs and biologicals, and requires interested vendors to submit a price schedule, a signed SF1449 cover page, valid state wholesale distributor licenses, and a Buy American Act certificate. The procurement is crucial for ensuring that veterans receive timely access to necessary pharmaceuticals, with the estimated RFP issue date set for March 6, 2025, and a response deadline of March 17, 2025. Interested parties should direct their submissions and inquiries to Contracting Officer Kelley Cunningham at kelley.cunningham@va.gov or by phone at 913-684-0140.
    6505--Carvedilol Tablets (VA-25-00048048)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carvedilol Tablets under solicitation number 36E79725R0028, aimed at ensuring a continuous supply for various federal health care entities, including the Department of Defense and the Bureau of Prisons. The contract will be for one year, with the possibility of four additional one-year extensions, requiring offerors to supply drugs labeled with their unique National Drug Code (NDC) without altering existing labels. This procurement is critical for maintaining the availability of essential medications for veterans and affiliated populations, underscoring the VA's commitment to effective health care delivery. Interested bidders should monitor SAM.gov for updates, with the RFP expected to be issued around March 19, 2025, and responses due by April 2, 2025; inquiries can be directed to Contract Specialist Adrienne Albachiara at adrienne.albachiara@va.gov or by phone at 708-202-9027.
    6505--Hydroxychloroquine SO4 Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Request for Proposal (RFP) for the procurement of Hydroxychloroquine SO4 Tablets, aimed at ensuring a continuous supply for various federal entities, including the Department of Defense and the Bureau of Prisons. The contract will cover an estimated annual requirement of 163,395 bottles of 100-count and 25,853 bottles of 500-count Hydroxychloroquine tablets, with a contract period of one year and four optional one-year extensions. This procurement is critical for maintaining essential medications within veteran and federal healthcare programs. Interested parties should monitor SAM.gov for updates and direct inquiries to the contracting officer, Chris Carthron, at Christopher.Carthron@va.gov or (708) 786-4980, with submissions due by March 26, 2025.
    6509--Solifenacin Tabletes (VA-25-00037090)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Solifenacin Tablets, designated as RFP 36E79725R0020. This procurement aims to establish a reliable supply of Solifenacin for the VA, Department of Defense (DoD), and other federal health agencies, with the contract expected to last one year and include four optional renewal periods. Solifenacin is a critical medication used in the treatment of overactive bladder, highlighting the VA's commitment to ensuring access to essential pharmaceuticals for veterans and associated healthcare providers. Interested vendors should monitor SAM.gov for the RFP release, anticipated around March 14, 2025, with proposals due by March 28, 2025; for further inquiries, they may contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov or by phone at 708-786-4879.
    36C77025Q0138_3 Pharm CLINs Charleston CMOP
    Buyer not available
    The Department of Veterans Affairs is soliciting bids for pharmaceutical supplies under requisition number 36C77025Q0138, specifically for the Charleston Consolidated Mail Outpatient Pharmacy (CMOP). The procurement includes a variety of pharmaceutical products, with requirements for compliance with federal regulations, including packaging and barcoding standards, and mandates that all supplies must have expiration dates exceeding one year from the delivery date. This initiative is crucial for ensuring that the Department can continue to provide quality healthcare services to veterans. Interested vendors must submit their quotes, including necessary documentation, by March 10, 2025, at 3:00 PM Central Time, and can direct inquiries to Lacie A Nowak at lacie.nowak@va.gov.
    DA10--FY25 - ScriptPro Service and Support (Base + 3) Northport
    Buyer not available
    The Department of Veterans Affairs, specifically the Network Contracting Office 2, intends to award a sole source contract to ScriptPro USA Inc. for the service and support of government-owned ScriptPro equipment at the Northport VA Medical Center. This contract will cover a base year from May 1, 2025, to April 30, 2026, with three optional renewal years, ensuring compliance with manufacturer standards and encompassing repairs, parts replacement, software updates, and technical support. The maintenance of this equipment is crucial for the operational standards of healthcare services provided to veterans. Interested firms may submit written notifications of capability by March 7, 2025, at 2:00 PM ET, via email to the primary contact, Lisa Harris, at Lisa.Harris4@va.gov.